Intragastric balloons are non-surgical medical devices widely applied in weight management therapies. Designed for temporary placement in the stomach, these devices reduce food intake and promote satiety, supporting weight reduction in individuals with overweight or obesity. This article reviews the structural design, clinical applications, and regulatory classification of intragastric balloons within Costa Rica’s healthcare system.
Structure and Function of Intragastric Balloons
An intragastric balloon system generally consists of a soft, expandable silicone balloon connected to an inflation catheter. The balloon is inserted endoscopically and inflated with sterile saline or air to occupy gastric space. This induces a sensation of fullness and helps patients lower caloric intake.
Advanced models may include adjustable inflation mechanisms, allowing volume modifications after placement without removal. This feature supports individualized treatment plans and improves patient tolerance during therapy.
Key components include:
- Silicone Balloon: Biocompatible and flexible, with a typical diameter around 90 mm.
- Inflation Catheter: Non-collapsible and permanently attached, enabling initial deployment and subsequent volume adjustments.
- Extension Tubing: polymer-based, with luer-lock connectors for secure inflation control.
- Insertion Accessories
- Inflation Syringe: Standard luer-lock syringe for balloon inflation and deflation.
Types of Intragastric Balloons
Intragastric balloons vary according to:
- Inflation Method: Saline-filled vs. air-filled.
Saline-filled systems are preferred in most procedures due to safety advantages. If leakage occurs, urine discoloration provides an early warning sign. Air-filled systems lack this indicator.
- Adjustability: Fixed-volume vs. adjustable-volume.
Adjustable systems allow patient-specific customization, improving clinical outcomes and reducing adverse events.
How Are Intragastric Balloons Classified and Grouped in Costa Rica?
In Costa Rica, intragastric balloons are considered surgically invasive devices intended to remain in the body for more than 30 consecutive days. Based on this criterion, they are classified as Class 3 medical devices. This classification reflects their invasive nature and prolonged contact with internal tissues.
Grouping Strategy for Registration:
Under Costa Rica’s regulatory framework, grouping is permitted when devices share the same intended use, manufacturer, and distinctive denomination. For intragastric balloons, grouping applies when:
- Models are packaged by the manufacturer together with implantation or filling accessories in the same sterilization tray or package.
- Components included are not considered standalone medical devices.
If any accessory (such as a syringe) is packaged separately and selected independently by the physician, it must be registered individually.
Conclusion
Intragastric balloons represent a structured, minimally invasive intervention for obesity management, offering both fixed and adjustable-volume options to enhance patient adherence. For stakeholders in the medical device industry, understanding Costa Rica’s classification system is key to ensuring proper registration, clinical integration, and compliance with post-market surveillance requirements.
- Need help evaluating your medical device for Costa Rican sanitary registration?
Contact Veraque for expert regulatory guidance.
- Looking for intragastric balloon distributors? Our database is your essential resource: explore it here.